AXSOME THERAPEUTICS INC (AXSM)
US05464T1043 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | 86.50M | 183.90M | 220.00M | |||
| Cash Equivalents | 386.19M | 200.80M | N/A | N/A | N/A | |||
| Receivables | 94.82M | 37.70M | N/A | N/A | N/A | |||
| Inventories | 15.13M | 4.30M | N/A | N/A | N/A | |||
| Other Current Assets | 8.12M | 2.80M | 0.00 | 100.00K | 400.00K | |||
| Total Current Assets | 504.26M | 245.60M | 86.50M | 184.00M | 220.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 7.62M | 1.10M | 900.00K | 1.80M | 0.00 | |||
| Goodwill | 12.04M | 10.30M | N/A | N/A | N/A | |||
| Intangibles | 53.29M | 59.70M | N/A | N/A | N/A | |||
| Other Non-Current Assets | 11.03M | 14.70M | 300.00K | 300.00K | 100.00K | |||
| Total Non-Current Assets | 83.97M | 85.90M | 1.30M | 2.10M | 100.00K | |||
| TOTAL ASSETS | 588.24M | 331.50M | 87.80M | 186.10M | 220.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 0.00 | 2.60M | |||
| Accrued Expenses | 91.77M | 52.10M | 9.90M | 9.90M | 10.90M | |||
| Accounts Payable | 40.68M | 38.60M | 13.10M | 13.50M | 10.90M | |||
| Other Current Liabilities | 6.41M | 5.90M | N/A | N/A | N/A | |||
| Total Current Liabilities | 138.85M | 96.60M | 23.10M | 23.40M | 24.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 178.07M | 94.30M | 49.10M | 48.30M | 17.30M | |||
| Other Non-Current Liabilities | 80.33M | 31.10M | 0.00 | 600.00K | N/A | |||
| Total Non-Current Liabilities | 258.40M | 125.30M | 49.10M | 48.90M | 17.30M | |||
| TOTAL LIABILITIES | 397.26M | 221.90M | 72.20M | 72.30M | 41.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -835.57M | -596.30M | -409.20M | -278.80M | -175.90M | |||
| Additional Paid In Capital | 1.03B | 705.90M | 424.80M | 392.60M | 354.60M | |||
| Common Shares | 5.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 47.35M | 43.50M | 37.80M | 37.40M | 36.90M | |||
| Tangible Book Value per Share | 2.65 | 0.91 | 0.41 | 3.04 | 4.84 | |||
| Total Shareholders' Equity | 190.98M | 109.60M | 15.60M | 113.80M | 178.70M | |||
| TOTAL LIABILITIES AND EQUITY | 588.24M | 331.50M | 87.80M | 186.10M | 220.50M | |||
| Statistics | ||||||||
| Debt/Equity | 0.93 | 0.86 | 3.15 | 0.42 | 0.10 | |||
| Current Ratio | 3.63 | 2.54 | 3.74 | 7.86 | 9.00 | |||
| Return On Assets (ROA) | -40.67% | -56.45% | -148.52% | -55.29% | -31.00% | |||
| Return On Equity (ROE) | -125.27% | -170.74% | -835.90% | -90.42% | -38.25% | |||
All data in USD